Preparation and in vitro evaluation of spray dried microparticles of antitubercular drugs for pulmonary delivery

International Journal of Pharmaceutical Sciences Review and Research

Volumn 12, Issue 2, 2012, Pages 120-128

  Jain, Parag Vijay ^a   Gudsoorkar, V R ^b   Jain, Dhara P ^c   Salunke, Kishore ^d  

^a S S P College of Pharmacy   (India)

^b Department of Pharmacology   (India)

^c S S D J Institute of Pharmaceutical Education and Research   (India)

^d Amrutvahini College of Pharmacy   (India)

Author keywords

Dry powder inhaler (DPI); Isoniazid; Mass median aerodynamic diameter (MMAD); Microparticles; Rifampicin; Tuberculosis (TB)

Indexed keywords

BIOPOLYMER; DRUG CARRIER; ISONIAZID; MANNITOL; POLY(DEXTRO LEVO LACTIDE); POLYGLACTIN; POLYLACTIC ACID; POLYMER; RIFAMPICIN; SUCROSE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BULK DENSITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IDENTIFICATION; DRUG PACKAGING; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; IN VITRO STUDY; PARTICLE SIZE; POWDER INHALER; PROCESS OPTIMIZATION; SPRAY DRYING; THERMOSTABILITY;

EID: 84856819643     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. T. R. Frieden, T. R. Sterling, S. S. Munsiff, C. J. Watt, C. Dye. Tuberculosis. The Lancet. 362(9398):2003, 1858-9.
2. H. P. Rang, M. M. Dale and J. M. Rither. Pharmacology, 4th Edn, Churchill Livingstone, London, 1997, 703-720.
3. R. Pandey, A. Zahoor, S. Sharma and G. K. Khuller. Nanoparticle encapsulated anti-tubercular drugs as a potential oral drug delivery system against tuberculosis. Tuberculosis (Edinb). 83:2003, 373-378.
4. C. P. Jain and S. P. Vyas. Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microencapsul. 12: 1995,401-407.
5. S. Nakhare and S. P. Vyas. Multiple emulsion based systems for prolonged delivery of rifampicin: in vitro and in vivo characterization. Die Pharmazie. 52:1997, 224-226.
6. E. Gavini, G. Rassu, C. Muzzarelli, M. Cossu and P. Giunchedi. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur. J. Pharm. Biopharm. 68(2): 2008, 245-253.
7. H. Nettey, D. Haswani, C.W. Oettinger and M. J. D'Souza. Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. J. Microencapsul. 23 (6):2006, 632-642.
8. C. G. Oster and T. Kissel. Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques. J. Microencapsul. 22(3):2005, 235-244.
9. B. B. Youan. Microencapsulation of superoxide dismutase into biodegradable microparticles by spray-drying. Drug Delivery. 11(3):2004, 209-214.
10. Naikwade, S., Bajaj, A., Preparation and in vitro evaluation of budesonide spray dried microparticles for pulmonary delivery. Sci. Pharm. 77:2009, 419-441.
11. N. Clarke, K. O'connor and Z. Ramtoola, Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying. Drug Dev. Ind. Pharm. 24 (2):1998, 169-174.
12. G. Khilnani and A. Banga. Aerosol therapy. J. Indian Acad Clin Med. 5:2004, 114-123.
13. S. P. Newman and W. W. Busse. Evolution of dry powder inhaler design, formulation and performance. Respir Med. 96:2002, 293-304.
14. M. J. Telko and A. J. Hickey. Dry powder inhaler formulation. Respir Care. 50:2005, 1209-1227.
15. N. Csaba, L. Gonzalez, A. Sanchez and M. J. Alonso. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J. Biomat. Scienc. Polymer. 15(9):2004, 1137-1151.
16. V. W. Bramwell and Y. Perrie. Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst. 22(2):2005, 151-214.
17. S. P. Vyas, M. E. Kannan, S. Jain, V. Mishra and P. Singh. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 269:2004, 37-49.
18. B. V. Parikh, S. M. Upadrashra, S. H. Neau. Oestrone loaded poly (l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics. J. Microencapsul. 10:1993, 141-153.
19. Y. Tozuka, H. Takeuchi. Fine particle design and preparations for pulmonary drug delivery. Drug Delivery System. 23 (4):2008, 467-473.
20. British Pharmacopoeia, Vol. 4, Her Majesty's Stationary Office, London, 2005, A277.
21. The United States Pharmacopoeia, Asian Edn., United States Pharmacopoeial Convention, Inc., Rockville, MD, 1995, 1838.
22. S. Shrenik and A. Misra. Liposomal Amikacin Dry Powder Inhaler: Effect of Fines on In Vitro Performance. AAPS PharmSciTech. 5 (4):2004, 65.
23. M. Chougule, B. Padhi and A. Misra. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. Int. J. Nanomedicine. 2(4):2007, 675-688.
24. R. L. Carr. Evaluating flow properties of solids. Chem. Eng. 72(3):1965, 163-168.
25. S. M. Hitendra, G. G. Surendra. Nasal administration of ondansetron using a novel microspheres delivery system. Pharm. Dev. Technol. 14(2):2009, 226-232.
26. B. Avinash, S. Steven and W. Karen. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA. Int. J. Pharm. 346(1-2):2008, 151-159.
27. C. Leticia and S. G. Silvia. High encapsulation efficiency of sodium alendronate in eudragit S100/HPMC blend microparticles. Quim. Nova. 32:2009, 5.
28. T. G. Park. Degradation of poly (D, L-Lactic acid) microspheres: effect of molecular weight. J. Control. Release. 30:1994, 161-173.
29. V. A. Philip, R. C. Mehta, M. K. Mazumdar and P. P. DeLuca. Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers. Int. J. Pharm. 151(2):1997, 165-174.